Jonathan Violin - 02 Jun 2021 Form 4 Insider Report for CATABASIS PHARMACEUTICALS INC (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Jonathan Violin
Issuer symbol
ATXS
Transactions as of
02 Jun 2021
Net transactions value
$0
Form type
4
Filing time
02 Jun 2021, 19:17:33 UTC
Next filing
22 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (right to buy) Award $0 +85,000 $0.000000 85,000 02 Jun 2021 Common Stock 85,000 $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 2, 2021 and is schedule to vest in equal annual installments over a three-year period from the date of grant, subject to the director's continued service.